# A Study of the Treatment of Postmenopausal Women With Osteoporosis

> **NCT00543023** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 104 (actual)

## Conditions studied

- Osteoporosis, Post-Menopausal

## Interventions

- **DRUG:** teriparatide 20 micrograms/day subcutaneous
- **DRUG:** salmon calcitonin 100 IU/day subcutaneous

## Key facts

- **NCT ID:** NCT00543023
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2007-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543023, "A Study of the Treatment of Postmenopausal Women With Osteoporosis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00543023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*